Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity

Jürgen K. Naggert, Lloyd D. Fricker, Oleg Varlamov, Patsy M. Nishina, Yves Rouille, Donald F. Steiner, Raymond J. Carroll, Beverly J. Paigen, Edward H. Leiter

    Research output: Contribution to journalArticle

    570 Scopus citations

    Abstract

    Mice homozygous for the fat mutation develop obesity and hyperglycaemia that can be suppressed by treatment with exogenous insulin. The fat mutation maps to mouse chromosome 8, very close to the gene for carboxypeptidase E (Cpe), which encodes an enzyme (CPE) that processes prohormone intermediates such as proinsulfn. We now demonstrate a defect in proinsulin processing associated with the virtual absence of CPE activity in extracts of fat/fat pancreatic islets and pituitaries. A single Ser202Pro mutation distinguishes the mutant Cpe allele, and abolishes enzymatic activity in vitro. Thus, the fat mutation represents the first demonstration of an obesity–diabetes syndrome elicited by a genetic defect in a prohormone processing pathway.

    Original languageEnglish (US)
    Pages (from-to)135-142
    Number of pages8
    JournalNature genetics
    Volume10
    Issue number2
    DOIs
    StatePublished - Jun 1995

    ASJC Scopus subject areas

    • Genetics

    Fingerprint Dive into the research topics of 'Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity'. Together they form a unique fingerprint.

  • Cite this

    Naggert, J. K., Fricker, L. D., Varlamov, O., Nishina, P. M., Rouille, Y., Steiner, D. F., Carroll, R. J., Paigen, B. J., & Leiter, E. H. (1995). Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nature genetics, 10(2), 135-142. https://doi.org/10.1038/ng0695-135